Yi-Wen Huang

Publication Activity (10 Years)

Years Active: 2019-2020
Publications (10 Years): 3

Top Topics

Tyrosine Kinase

Coronavirus Disease

Advanced Non Small Cell Lung Cancer

Top Venues

International journal of environmental research and public health

Diagnostics (Basel, Switzerland)

Changhua Hospital

Chung Shan Medical University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Changhua Hospital

Taiwan

Chief :: Acute and Critical Care

Taiwan Society of Tuberculosis and lung diseases

Taiwan

Director

Centers for Disease Control

Taiwan

Deputy commander :: Central Region Communicable Disease Control Medical Network

Changhua Hospital

Taiwan

Chief :: Pulmonary and Critical Care Unit

Changhua Hospital

Taiwan

Chief :: Tuberculosis Department

Education History

Chung Shan Medical University

Taiwan

PHD

Kaohsiung Medical University

Taiwan

BSC :: Medical

Publications

Ya-Yen Yu, Hui-Ling Chiou, Shih-Ming Tsao, Chen-Cheng Huang, Chih-Yun Lin, Chia-Yi Lee, Thomas Chang-Yao Tsao, Chiao-Wen Lin, Yi-Wen Huang
Association of Carbonic Anhydrase 9 Polymorphism and the Epithelial Growth Factor Receptor Mutations in Lung Adenocarcinoma Patients. Diagnostics (Basel, Switzerland) 10 (5) (2020)
Cheng-Pin Chen, Yi-Chun Lin, Tsung-Chia Chen, Ting-Yu Tseng, Hon-Lai Wong, Cheng-Yu Kuo, Wu-Pu Lin, Sz-Rung Huang, Wei-Yao Wang, Jia-Hung Liao, Chung-Shin Liao, Yuan-Pin Hung, Tse-Hung Lin, Tz-Yan Chang, Chin-Fu Hsiao, Yi-Wen Huang, Wei-Sheng Chung, Chien-Yu Cheng, Shu-Hsing Cheng, null null
A multicenter, randomized, open-label, controlled trial to evaluate the efficacy and tolerability of hydroxychloroquine and a retrospective study in adult patients with mild to moderate coronavirus disease 2019 (COVID-19). PloS one 15 (12) (2020)
Ya-Yen Yu, Shih-Ming Tsao, Wen-Ta Yang, Wei-Chang Huang, Ching-Hsiung Lin, Wei-Wen Chen, Chiao-Wen Lin, Hui-Ling Chiou, Yi-Wen Huang
Association of Drug Metabolic Enzyme Genetic Polymorphisms and Adverse Drug Reactions in Patients Receiving Rifapentine and Isoniazid Therapy for Latent Tuberculosis. International journal of environmental research and public health 17 (1) (2019)